Extracellular ATP triggers proteolysis and cytosolic Ca2+ rise in Plasmodium berghei and Plasmodium yoelii malaria parasites


Autoria(s): Cruz, Laura Nogueira; Juliano, Maria Aparecida; Budu, Alexandre; Juliano, Luiz; Holder, Anthony A.; Blackman, Michael J.; Garcia, Celia R. S.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

17/09/2013

17/09/2013

2012

Resumo

Background: Plasmodium has a complex cell biology and it is essential to dissect the cell-signalling pathways underlying its survival within the host. Methods: Using the fluorescence resonance energy transfer (FRET) peptide substrate Abz-AIKFFARQ-EDDnp and Fluo4/AM, the effects of extracellular ATP on triggering proteolysis and Ca2+ signalling in Plasmodium berghei and Plasmodium yoelii malaria parasites were investigated. Results: The protease activity was blocked in the presence of the purinergic receptor blockers suramin (50 mu M) and PPADS (50 mu M) or the extracellular and intracellular calcium chelators EGTA (5 mM) and BAPTA/AM (25, 100, 200 and 500 mu M), respectively for P. yoelii and P. berghei. Addition of ATP (50, 70, 200 and 250 mu M) to isolated parasites previously loaded with Fluo4/AM in a Ca2+-containing medium led to an increase in cytosolic calcium. This rise was blocked by pre-incubating the parasites with either purinergic antagonists PPADS (50 mu M), TNP-ATP (50 mu M) or the purinergic blockers KN-62 (10 mu M) and Ip5I (10 mu M). Incubating P. berghei infected cells with KN-62 (200 mu M) resulted in a changed profile of merozoite surface protein 1 (MSP1) processing as revealed by western blot assays. Moreover incubating P. berghei for 17 h with KN-62 (10 mu M) led to an increase in rings forms (82% +/- 4, n = 11) and a decrease in trophozoite forms (18% +/- 4, n = 11). Conclusions: The data clearly show that purinergic signalling modulates P. berghei protease(s) activity and that MSP1 is one target in this pathway.

FAPESP

FAPESP

CNPq InBqmed

CNPq - InBqmed

UK Medical Research Council

UK Medical Research Council [U117532067, U117532063]

EU through the Network of Excellence EviMalaR

EU through the Network of Excellence EviMalaR [Health-2009-2.3.2-1-242095]

Identificador

MALARIA JOURNAL, LONDON, v. 11, n. 4, supl. 6, Part 1, pp. 83-87, 42064, 2012

1475-2875

http://www.producao.usp.br/handle/BDPI/33405

10.1186/1475-2875-11-69

http://dx.doi.org/10.1186/1475-2875-11-69

Idioma(s)

eng

Publicador

BIOMED CENTRAL LTD

LONDON

Relação

MALARIA JOURNAL

Direitos

openAccess

Copyright BIOMED CENTRAL LTD

Palavras-Chave #ATP #PURINERGIC RECEPTOR #MALARIA #PLASMODIUM BERGHEI #PLASMODIUM YOELII #PROTEASE ACTIVITY #CALCIUM MODULATION #MEROZOITE SURFACE PROTEIN 1 #RED-BLOOD-CELLS #PFNT1 NUCLEOSIDE TRANSPORTER #MEROZOITE SURFACE PROTEIN-1 #LIZARDS AMEIVA-AMEIVA #PLASMA-MEMBRANE #SIGNAL-TRANSDUCTION #GENOME SEQUENCE #PURINE SALVAGE #LIFE-CYCLE #FALCIPARUM #PARASITOLOGY #TROPICAL MEDICINE
Tipo

article

original article

publishedVersion